John Libbey Eurotext

Hépato-Gastro & Oncologie Digestive

MENU

Transcatheter Aortic Valve Implantation and cirrhosis Volume 28, issue 3, Mars 2021

Figures

  • Figure 1
  • Figure 2

Tables

Authors
CHU Lille, Hôpital Claude Huriez, Maladies appareil digestif, Pole médico-chirurgical, 59037 Lille Cedex
* Correspondance

Aortic stenosis is a common valve pathology. Its tight or symptomatic presentation has a poor prognosis without valve replacement and constitutes a contraindication to liver transplantation. Its surgical management in cirrhotic patients is associated with significant morbidity and mortality. The emergence of percutaneous aortic valve replacement or TAVI (Transcathether Aortic Valve Implantation) offers an attractive alternative. TAVI may help restore eligibility for liver transplantation or allow elective surgical procedures to be performed in these patients. The prevention of post-procedural complications, in particular hemorrhagic complications, is still poorly codified.